Quick Answer
ProPhase Labs, Inc. reported Shares Outstanding of 29.87 million shares for fiscal year 2024.
ProPhase Labs, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2024 | 29.87M | +65.6% |
| 2023 | 18.05M | +11.3% |
| 2022 | 16.21M | +4.7% |
| 2021 | 15.49M | +33.5% |
| 2020 | 11.60M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 41.54M | +117.7% | +0.0% |
| June 30, 2025 | 41.54M | +117.7% | +0.0% |
| March 31, 2025 | 41.54M | +130.2% | +39.1% |
| December 31, 2024 | 29.87M | +65.6% | +56.6% |
| September 30, 2024 | 19.08M | +5.7% | +0.0% |
| June 30, 2024 | 19.08M | +13.3% | +5.7% |
| March 31, 2024 | 18.05M | +7.1% | +0.0% |
| December 31, 2023 | 18.05M | +11.3% | +0.0% |
- ProPhase Labs, Inc. showed an increase of +65.6% in Shares Outstanding compared to the prior fiscal year.
- Over the 2020–2024 period, ProPhase Labs, Inc.’s shares outstanding has grown by 157.4% (from 11.60 million shares to 29.87 million shares).
- The most recent figure is from ProPhase Labs, Inc.’s fiscal year 2024 report (Form 10-K), filed with the SEC on April 1, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: